|
1
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dykxhoorn DM: MicroRNAs and metastasis:
little RNAs go a long way. Cancer Res. 70:6401–6406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rebane A and Akdis CA: MicroRNAs:
Essential players in the regulation of inflammation. J Allergy Clin
Immunol. 132:15–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Szabo G and Bala S: MicroRNAs in liver
disease. Nat Rev Gastroenterol Hepatol. 10:542–552. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu BL, Xu LY, Du ZP, et al: MiRNA profile
in esophageal squamous cell carcinoma: downregulation of miR-143
and miR-145. World J Gastroenterol. 17:79–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
South AP, Cho RJ and Aster JC: The
double-edged sword of Notch signaling in cancer. Semin Cell Dev
Biol. 23:458–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohashi S, Natsuizaka M, Yashiro-Ohtani Y,
et al: NOTCH1 and NOTCH3 coordinate esophageal squamous
differentiation through a CSL-dependent transcriptional network.
Gastroenterology. 139:2113–2123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stange DE and Clevers H: Concise review:
the yin and yang of intestinal (cancer) stem cells and their
progenitors. Stem Cells. 31:2287–2295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Louvi A and Artavanis-Tsakonas S: Notch
signalling in vertebrate neural development. Nat Rev Neurosci.
7:93–102. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu C, Chen K, Zheng H, et al:
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated
with esophageal squamous cell carcinoma (ESCC) progression and
pathogenesis. Carcinogenesis. 30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Le XF, McWatters A, Wiener J, Wu JY, Mills
GB and Bast RC Jr: Anti-HER2 antibody and heregulin suppress growth
of HER2-overexpressing human breast cancer cells through different
mechanisms. Clin Cancer Res. 6:260–270. 2000.PubMed/NCBI
|
|
13
|
Le XF, Almeida MI, Mao W, et al:
Modulation of MicroRNA-194 and cell migration by HER2-targeting
trastuzumab in breast cancer. PLoS One. 7:e411702012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gargalionis AN and Basdra EK: Insights in
microRNAs biology. Curr Top Med Chem. 13:1493–1502. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suzuki H, Maruyama R, Yamamoto E and Kai
M: DNA methylation and microRNA dysregulation in cancer. Mol Oncol.
6:567–578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schmitt MJ, Margue C, Behrmann I and Kreis
S: MiRNA-29: a microRNA family with tumor-suppressing and
immune-modulating properties. Curr Mol Med. 13:572–585. 2013.
View Article : Google Scholar
|
|
17
|
Kriegel AJ, Liu Y, Fang Y, Ding X and
Liang M: The miR-29 family: genomics, cell biology, and relevance
to renal and cardiovascular injury. Physiol Genomics. 44:237–244.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garzon R, Garofalo M, Martelli MP, et al:
Distinctive microRNA signature of acute myeloid leukemia bearing
cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA.
105:3945–3950. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garzon R, Heaphy CE, Havelange V, et al:
MicroRNA 29b functions in acute myeloid leukemia. Blood.
114:5331–5341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nguyen T, Kuo C, Nicholl MB, et al:
Downregulation of microRNA-29c is associated with hypermethylation
of tumor-related genes and disease outcome in cutaneous melanoma.
Epigenetics. 6:388–394. 2011. View Article : Google Scholar :
|
|
21
|
Xiong Y, Fang JH, Yun JP, et al: Effects
of microRNA-29 on apoptosis, tumorigenicity, and prognosis of
hepatocellular carcinoma. Hepatology. 51:836–845. 2010.
|
|
22
|
Cummins JM, He Y, Leary RJ, et al: The
colorectal microRNAome. Proc Natl Acad Sci U S A. 103:3687–3692.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Wang F, Xu J, et al: Progressive
miRNA expression profiles in cervical carcinogenesis and
identification of HPV-related target genes for miR-29. J Pathol.
224:484–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu Z, Huang X, Huang X, Zou Q and Guo Y:
The inhibitory role of Mir-29 in growth of breast cancer cells. J
Exp Clin Cancer Res. 32:982013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu XC, Dong QZ, Zhang XF, et al:
microRNA-29a suppresses cell proliferation by targeting SPARC in
hepatocellular carcinoma. Int J Mol Med. 30:1321–1326.
2012.PubMed/NCBI
|
|
27
|
Calin GA, Ferracin M, Cimmino A, et al: A
MicroRNA signature associated with prognosis and progression in
chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pekarsky Y, Santanam U, Cimmino A, et al:
Tcl1 expression in chronic lymphocytic leukemia is regulated by
miR-29 and miR-181. Cancer Res. 66:11590–11593. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sengupta S, Den Boon JA, Chen IH, et al:
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas,
up-regulating mRNAs encoding extracellular matrix proteins. Proc
Nat Acad Sci USA. 105:5874–5878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Kong D, Ahmad A, Bao B, Dyson G and
Sarkar FH: Epigenetic deregulation of miR-29a and miR-1256 by
isoflavone contributes to the inhibition of prostate cancer cell
growth and invasion. Epigenetics. 7:940–949. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ohashi S, Natsuizaka M, Naganuma S, et al:
A NOTCH3-mediated squamous cell differentiation program limits
expansion of EMT-competent cells that express the ZEB transcription
factors. Cancer Res. 71:6836–6847. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Piper M, Barry G, Hawkins J, et al: NFIA
controls telencephalic progenitor cell differentiation through
repression of the Notch effector Hes1. J Neurosci. 30:9127–9139.
2010. View Article : Google Scholar : PubMed/NCBI
|
